Article
Front. Oncol., Sec. Cancer Immunity and Immunotherapy,  

Safety and Therapeutic Profile of a GnRH-Based Vaccine Candidate Directed to Prostate Cancer. A 10-Year Follow-Up of Patients Vaccinated With Heberprovac”.

Junco J, Rodríguez R, Fuentes F, …Moran R, et al.